Admission Date:  [**2181-3-14**]              Discharge Date:   [**2181-3-22**]  Date of Birth:  [**2114-9-18**]             Sex:   F  Service: MEDICINE  Allergies: Penicillins / Sulfa (Sulfonamide Antibiotics) / Bactrim / SEROVENT / fentanyl / midazolam  Attending:[**First Name3 (LF) 2186**] Chief Complaint: Obtundation  Major Surgical or Invasive Procedure: None  History of Present Illness:  66 female with PMHx significant for DM2, HTN, gastric adenocarcinoma who was recently discharged from [**Hospital1 18**] on [**2181-3-7**] s/p subtotal gastrectomy on [**2181-2-21**] who now presents after being found obtunded [**2181-3-14**] at home.
.The patient states that she has been taking her insulin as prescribed since leaving the hospital.
She was started on long-acting insulin prior to discharge with a plan to follow up with [**Last Name (un) **] as an outpatient.
In the ED: Initial VS: 97.4  127  34  92/47  100 % on NRB On arrival, FSBG read critically high.
The patient was given 10 units IV insulin bolus & started on insulin gtt at 10 units per hour.
In total, she received 5.5 L NS in the ED.
As such, the patient was given calcium gluconate.
The patient was started on IV levofloxacin and IV vancomycin for presumed CAP.
IV Flagyl was subsequently started to cover intra-abdominal pathogens.
On [**2181-3-16**], C. diff was negative, so IV flagyl was discontinued.
CXR was negative so vancomycin was stopped and a decision to continue cefepime for 7 day course ([**Date range (3) 92936**]) was made.
Denies visual changes, headache, dizziness, sinus tenderness, neck stiffness, rhinorrhea, congestion, sore throat or dysphagia.
Past Medical History: Gastric adenocarcinoma (dx [**9-/2180**]) Ductal carcinoma of breast: T1c, N0, M0 stage IB hypertension hyperlipidemia diabetes venous insufficiency OSA rheumatic heart disease asthma factor VIII inhibitor  PSH: Subtotal gastrectomy [**2181-2-21**] R Mastectomy b/l vitrectomy b/l cataracts   Social History: Lives with her husband.
Physical Exam: Admission Exam: VS: 98.3 149/57 98 20 98% RA;  0/10  pain GEN: No apparent distress HEENT: no trauma, pupils round and reactive to light and accommodation, no LAD, oropharynx clear, no exudates CV: regular rate and rhythm, no murmurs/gallops/rubs PULM: Clear to auscultation bilaterally, no rales/crackles/rhonchi GI: soft, non-tender, non-distended; no guarding/rebound;surgical scar c/d/i EXT: no clubbing/cyanosis/edema; 2+ distal pulses; peripheral IV present NEURO: Alert and oriented to person, place and situation; CN II-XII intact, [**3-31**] motor function globally DERM: no lesions appreciated    Pertinent Results: [**2181-3-14**] 11:47PM   TYPE-[**Last Name (un) **] PO2-41* PCO2-40 PH-7.31* TOTAL CO2-21 BASE XS--5 [**2181-3-14**] 11:47PM   GLUCOSE-110* LACTATE-4.3* NA+-137 K+-3.9 CL--108 [**2181-3-14**] 08:30PM   GLUCOSE-225* LACTATE-3.7* NA+-135 K+-3.8 CL--106 TCO2-22 [**2181-3-14**] 07:53PM URINE  COLOR-Yellow APPEAR-Hazy SP [**Last Name (un) 155**]-1.019 [**2181-3-14**] 07:53PM URINE  BLOOD-MOD NITRITE-NEG PROTEIN-30 GLUCOSE-150 KETONE-10 BILIRUBIN-SM  UROBILNGN-2* PH-5.5 LEUK-TR [**2181-3-14**] 07:53PM URINE  RBC-16* WBC-7* BACTERIA-NONE YEAST-NONE EPI-0 [**2181-3-14**] 07:53PM URINE  GRANULAR-8* HYALINE-8* [**2181-3-14**] 07:53PM URINE  AMORPH-RARE [**2181-3-14**] 07:53PM URINE  MUCOUS-RARE [**2181-3-14**] 07:52PM   GLUCOSE-236* UREA N-15 CREAT-1.3* [**2181-3-14**] 07:52PM   CALCIUM-8.0* PHOSPHATE-1.2* MAGNESIUM-1.7 [**2181-3-14**] 06:16PM   GLUCOSE-165* NA+-134 K+-3.9 CL--105 TCO2-21 [**2181-3-14**] 05:56PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.016 [**2181-3-14**] 05:56PM URINE  BLOOD-MOD NITRITE-NEG PROTEIN-30 GLUCOSE->1000 KETONE-10 BILIRUBIN-MOD UROBILNGN-4* PH-5.0 LEUK-TR [**2181-3-14**] 05:56PM URINE  RBC-8* WBC-5 BACTERIA-NONE YEAST-NONE EPI-0 [**2181-3-14**] 05:56PM URINE  HYALINE-9* [**2181-3-14**] 05:56PM URINE  MUCOUS-RARE [**2181-3-14**] 04:23PM   GLUCOSE-284* LACTATE-2.7* NA+-135 K+-4.1 CL--102 TCO2-22 [**2181-3-14**] 03:09PM   TYPE-MIX PH-7.30* [**2181-3-14**] 03:09PM   GLUCOSE-349* LACTATE-2.8* NA+-134 K+-4.7 CL--104 TCO2-20* [**2181-3-14**] 03:09PM   freeCa-1.17 [**2181-3-14**] 03:04PM   GLUCOSE-390* UREA N-15 CREAT-1.5* SODIUM-136 POTASSIUM-4.8 CHLORIDE-104 TOTAL CO2-20* ANION GAP-17 [**2181-3-14**] 03:04PM   CALCIUM-8.1* PHOSPHATE-1.5*# MAGNESIUM-1.9 [**2181-3-14**] 02:53PM   VoidSpec-CLOTTED SP [**2181-3-14**] 01:44PM   TYPE-CENTRAL VE PH-7.30* [**2181-3-14**] 01:44PM   GLUCOSE-416* [**2181-3-14**] 01:44PM   freeCa-1.19 [**2181-3-14**] 12:53PM   TYPE-MIX [**2181-3-14**] 12:53PM   GLUCOSE-458* LACTATE-3.7* NA+-135 K+-3.9 CL--104 TCO2-15* [**2181-3-14**] 11:38AM   GLUCOSE-497* [**2181-3-14**] 10:30AM   TYPE-ART TEMP-36.4 O2 FLOW-2 PO2-116* PCO2-21* PH-7.25* TOTAL CO2-10* BASE XS--15 INTUBATED-NOT INTUBA COMMENTS-NASAL [**Last Name (un) 154**] [**2181-3-14**] 10:30AM   LACTATE-5.1* NA+-136 K+-4.1 CL--105 [**2181-3-14**] 10:30AM   O2 SAT-97 [**2181-3-14**] 10:22AM   GLUCOSE-659* UREA N-17 CREAT-1.6* SODIUM-136 POTASSIUM-4.2 CHLORIDE-100 TOTAL CO2-9* ANION GAP-31* [**2181-3-14**] 10:22AM   CALCIUM-7.8* PHOSPHATE-3.9 MAGNESIUM-1.5* [**2181-3-14**] 10:22AM   WBC-21.0* RBC-2.27* HGB-6.9* HCT-24.4* MCV-108*# MCH-30.4 MCHC-28.3*# RDW-18.1* [**2181-3-14**] 10:22AM   PLT COUNT-382 [**2181-3-14**] 07:56AM   LACTATE-7.7* [**2181-3-14**] 07:50AM   GLUCOSE-768* UREA N-18 CREAT-1.7* SODIUM-137 POTASSIUM-4.8 CHLORIDE-97 TOTAL CO2-5* ANION GAP-40* [**2181-3-14**] 07:50AM   ACETONE-LARGE OSMOLAL-338* [**2181-3-14**] 07:10AM   TYPE-[**Last Name (un) **] TEMP-36.8 PO2-89 PCO2-21* PH-6.98* TOTAL CO2-5* BASE XS--26 [**2181-3-14**] 06:35AM URINE  HOURS-RANDOM [**2181-3-14**] 06:35AM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG mthdone-NEG [**2181-3-14**] 06:35AM URINE  COLOR-Straw APPEAR-Clear SP [**Last Name (un) 155**]-1.012 [**2181-3-14**] 06:35AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-1000 KETONE-80 BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2181-3-14**] 06:19AM   TYPE-[**Last Name (un) **] PO2-115* PCO2-20* PH-7.07* TOTAL CO2-6* BASE XS--23 [**2181-3-14**] 06:19AM   LACTATE-9.1* [**2181-3-14**] 06:10AM   GLUCOSE-843* UREA N-17 CREAT-1.7* SODIUM-135 POTASSIUM-5.3* CHLORIDE-90* TOTAL CO2-6* ANION GAP-44* [**2181-3-14**] 06:10AM   estGFR-Using this [**2181-3-14**] 06:10AM   ALT(SGPT)-12 AST(SGOT)-16 ALK PHOS-71 TOT BILI-0.2 [**2181-3-14**] 06:10AM   LIPASE-11 [**2181-3-14**] 06:10AM   ALBUMIN-2.9* [**2181-3-14**] 06:10AM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG [**2181-3-14**] 06:10AM   WBC-18.2*# RBC-2.34* HGB-6.8* HCT-27.6* MCV-118*# MCH-29.2 MCHC-24.7*# RDW-18.3* [**2181-3-14**] 06:10AM   NEUTS-90* BANDS-0 LYMPHS-7* MONOS-2 EOS-1 BASOS-0 ATYPS-0 METAS-0 MYELOS-0 [**2181-3-14**] 06:10AM   HYPOCHROM-NORMAL ANISOCYT-2+ POIKILOCY-3+ MACROCYT-2+ MICROCYT-NORMAL POLYCHROM-NORMAL OVALOCYT-OCCASIONAL TARGET-OCCASIONAL SCHISTOCY-OCCASIONAL BURR-3+ [**2181-3-14**] 06:10AM   PLT SMR-NORMAL PLT COUNT-405 [**2181-3-14**] 06:10AM   PT-12.4 PTT-30.5 INR(PT)-1.1  IMMAGING: [**2181-3-14**]   Radiology CHEST (PORTABLE AP): PORTABLE AP CHEST RADIOGRAPH: In the interim since the prior examination, there has been removal of the feeding tube and right central line.
A right Port-A-Cath tip projects over the cavoatrial junction.
The visualized heart and pericardium are unremarkable.
The bladder is decompressed with Foley catheter in place.
The patient is status post partial gastrectomy.
Patient is status post partial gastrectomy with no intra-abdominal findings to explain patient's symptoms.
A right subclavian infusion port, ends in the mid SVC.
[**2181-3-14**]  BLOOD CULTURE  Pending  Brief Hospital Course: 66 F DM2, recent subtotal gastrectomy for gastric adenocarcinoma, p/w DKA & ARF.
DKA: Ms. [**Known lastname 50155**] was admitted on [**3-14**] with significant obtundation and acidosis.
She was admitted to the ICU and treated with insulin bolus and subsequently with insulin gtt.
There was a substantial free water deficit and she was aggressively hydrated and repleted with electrolytes when needed.
With this regimen, the anion gap closed and she was transitioned to SQ insulin and iv D5 with better control.
She and her husband have both stated that she has been taking her insulin as instructed.
Flagyl was empirically given for possible C.diff, but stool c.diff returned negative.
Subsequent CXR revealed no evidence of infection and so the abx regimen was switched simply to cipro.
A 7-day empiric treatment course of cipro was given - for the low-possibility that pneumonia was present on admission.
GI: the patient is s/p gastrectomy on [**2181-2-21**] for gastric adenocarcinoma.
Incision did not appear infected.
She was treated with morphine and oxycodone prn.
Reglan was continued and ativan PRN was given.
Ativan appeared to be most effective in relieving her nausea.
Hyperlipidemia: Continued home rosuvastatin .
Continued home duloxetine .
Metoprolol and verapamil were held in ICU.
Metoprolol was restarted on the floor.
She continue on her home valsartan.
Venous stasis: Lasix was initially held but was restarted on transfer to the floor.
Gastric adenocarcinoma: Last chemo [**2181-1-22**]: Cycle 3, day 1 of epirubicin and Xeloda.
She continues to be substantially weakened from her hospitalization, recent surgeries, DKA, and chemotherapy regimen.
FEN:heart healthy, diabetic diet .
Prophylaxis: Heparin sub-Q 5000 Units TID for VTE prophylaxis.
Code Status: Full Code (confirmed with HCP, pt's husband)  Medications on Admission: Home medication list (as per d/c summary [**2181-3-7**]):  1. albuterol sulfate 90 mcg/actuation HFA 2 puffs Inhalation twice a day 2.
ProAir HFA 90 mcg/actuation HFA Aerosol 2 puffs Inh q4-6 hours prn sob 3.
Vitamin B-12 1,000 mcg/mL Solution Injection 4. duloxetine 30 mg E.C.
2 capsules PO Daily 5. fluticasone 220 mcg/actuation Aerosol Sig: 2-5 puffs Inh twice a day 6. furosemide 40 mg Tablet Sig: One (1) Tablet PO qam 7. furosemide 20 mg Tablet Sig: One (1) Tablet PO qpm 8. metoprolol tartrate 50 mg 1 Tablet PO BID 9.
Singulair 10 mg 1 Tablet PO daily 10. omeprazole 20 mg E.C.
PO daily 11. prazosin 2 mg 2 Capsules PO BID 12.
Maxalt-MLT 10 mg Rapid Dissolve 1 Tablet PO once a day 13. rosuvastatin 5 mg 2 Tablet PO daily 14.
Diovan 320 mg Tablet Sig: One (1) Tablet PO once a day 15. verapamil 180 mg E.R.
Xeloda 500 mg 2 Tablets PO twice a day 18. lorazepam 0.5 mg 1 Tablet PO Q4H as needed for anxiety 19. nystatin 100,000 unit/mL Suspension 5 mL PO twice a day.
20. ondansetron 8 mg Rapid Dissolve 1 Tablet PO every 8 hours prn nausea 21. prochlorperazine maleate 1 po prn nausea 22. oxycodone 5 mg 1-2 Tablets PO Q4H prn pain 23. docusate sodium 100 mg 1 Tablet PO once a day 24. metoclopramide 5 mg 1 Tablet PO four times a day 25.
Humalog 100 unit/mL Per sliding scale Sub-Q2 hours after meals and QHS 26.
Lantus 100 unit/mL 12 units Subcutaneous at bedtime  Discharge Medications: 1. metoprolol tartrate 50 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
2. furosemide 40 mg Tablet Sig: One (1) Tablet PO QAM (once a day (in the morning)).
3. furosemide 20 mg Tablet Sig: One (1) Tablet PO QPM (once a day (in the evening)).
4. valsartan 160 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
5. rosuvastatin 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
6. metoclopramide 5 mg/5 mL Solution Sig: One (1)  PO QID (4 times a day).
7. omeprazole 20 mg Capsule, Delayed Release(E.C.)
8. duloxetine 30 mg Capsule, Delayed Release(E.C.)
Ativan 0.5 mg Tablet Sig: 0.5 Tablet PO every four (4) hours as needed for nausea: Please take only 0.25 mg (half a 0.5 mg tablet) as needed for nausea.
Disp:*30 Tablet(s)* Refills:*1* 10. ondansetron HCl 4 mg Tablet Sig: One (1) Tablet PO every eight (8) hours.
12. montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Discharge Disposition: Home With Service  Facility: [**Hospital 119**] Homecare  Discharge Diagnosis: Primary Diagnosis - DKA  Secondary Diagnoses - Gastric Mass s/p gastrectomy - Diabetes type 2 - Hypertension - ?
Your sugars improved with IV insulin.
Your medications were adjusted to help control your symptoms.
Ativan can be taken as needed for nausea  Followup Instructions: Name: [**Hospital **] [**Name Initial (MD) **] [**Name8 (MD) 1395**],  MD Specialty: Primary Care When: Monday [**3-26**] at 9:30am Location: [**Hospital1 **] HEALTHCARE - [**State 3753**]GROUP Address: [**State **], [**Apartment Address(1) 3745**], [**Location (un) **],[**Numeric Identifier 822**] Phone: [**Telephone/Fax (1) 2205**]  We are working on a follow up appointment with Dr. [**Last Name (STitle) **] in the next 1-2 weeks.
Please contact Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] office at [**Last Name (un) **] Diabetes Center to have a follow up appt within the next 1-2 weeks  Name: [**Last Name (un) **] [**Name Initial (MD) **] [**Name8 (MD) 1395**],  MD Specialty: Primary Care When: Monday [**3-26**] at 9:30am Location: [**Hospital1 **] HEALTHCARE - [**State 3753**]GROUP Address: [**State **], [**Apartment Address(1) 3745**], [**Location (un) **],[**Numeric Identifier 822**] Phone: [**Telephone/Fax (1) 2205**]  We are working on a follow up appointment with Dr. [**Last Name (STitle) **] in the next 1-2 weeks.
